Tia Ling

CD8-positive CTCLs remain a diagnostic challenge. CD8+ MF in adults exhibit dual growth patterns: localized or systemically disseminated disease. The latter could have a very short median overall survival regardless of the aggressive therapies. Allo-HSCT might be beneficial to those with AECTL. Larger series of CD8+ MF should be investigated for molecular gene profiling in order to establish genetic, molecular and phenotypic parameters not only to separate the indolent form from the aggressive subtype, but also to distinguish it from primary cutaneous CD8-positive AECTL.

tia ling

Download Zip: https://www.google.com/url?q=https%3A%2F%2Furlcod.com%2F2uf2mA&sa=D&sntz=1&usg=AOvVaw0mQJI8C_IXMJIuh16DgrQR

041b061a72